Seeger Weiss Announces Settlement with Philips to Resolve Economic Loss Claims for Recalled CPAPs, Bi-PAPs, And Ventilators

Today, Seeger Weiss founding partner Chris Seeger, who serves as co-lead counsel in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation, announced a settlement worth a minimum of $479M on behalf of device users who purchased or rented recalled devices and payers who reimbursed users for the cost of recalled devices. “This […]

September 7, 2023

Today, Seeger Weiss founding partner Chris Seeger, who serves as co-lead counsel in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation, announced a settlement worth a minimum of $479M on behalf of device users who purchased or rented recalled devices and payers who reimbursed users for the cost of recalled devices.

“This settlement provides substantial monetary compensation to those who were sold or paid for defective devices by Philips and is an important step towards justice. Once approved by the court, we encourage all members of the nationwide settlement class to avail themselves of the benefits provided under the agreement,” said Seeger, along with plaintiffs’ co-lead counsel Sandra Duggan, Kelly Iverson, and Steven Schwartz.

The tireless efforts of Seeger Weiss attorneys David Buchanan, Shauna Itri, Caleb Seeley, Humaira Safdar and Fraz Thomas were instrumental in achieving this settlement for all device users and payers affected by the recall. And this significant resolution would not have been possible without important contributions from Seeger Weiss litigation and case management attorneys and support staff.

This settlement only resolves the economic loss portion of the litigation and does not cover personal injury and medical monitoring claims. Seeger Weiss will continue to pursue justice and hold Philips accountable on behalf of its personal injury clients and seek a medical monitoring program for all those affected by the recall.

One of the nation’s preeminent plaintiffs’ law firms, Seeger Weiss is best known for multidistrict mass torts and class actions in both state and federal court—and especially for taking those cases to trial. With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. From offices in New York, New Jersey, and Pennsylvania, the firm has represented over 10,000 individuals, companies, and governments across the United States who have been injured or defrauded on a massive scale. Since its founding in 1999, it has led many of the most complex and high-profile cases in the country: the National Prescription Opiate Litigation, which the Washington Post called “the largest federal court case in U.S. history”; the ongoing “Dieselgate” scandal; the sprawling multistate litigation on behalf of survivors of child sexual abuse; and the history-making National Football League Players’ Concussion Injury Litigation.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

March 26, 2026
Jury Finds Meta and YouTube Liable in Landmark California Social Media Addiction Trial

A California jury has found Meta and YouTube negligent in designing platforms that harmed a young user, ordering Meta to pay $4.2 million and YouTube to pay $1.8 million in combined compensatory and punitive damages, in what is being called a landmark verdict in social media addiction litigation. Seeger Weiss Founding Partner Christopher Seeger serves […]

Read More
March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More